$NNOXOct 16, 2026, 8:00 AM ETAI processed
Nanox (NNOX) subsidiary inks distribution deal to sell HealthOST bone-AI in Italy
AI Summary
Nanox AI (subsidiary of Nano‑X Imaging, NNOX) signed a distribution agreement with Technologic s.r.l. (affiliate of Tecnologie Avanzate) to commercialize its HealthOST bone assessment AI in Italy to expand its commercial presence. HealthOST analyzes eligible routine CT scans to provide quantitative and qualitative spine assessments that can help identify patients at risk for osteoporosis and prompt further evaluation, while the partner brings ~50 years of local medtech experience to support market entry.
Positives
- Signed distribution agreement with Technologic s.r.l. to commercialize HealthOST in Italy
- HealthOST leverages existing routine CT scans to flag potential osteoporosis/musculoskeletal risk without new imaging
- Partner (Tecnologie Avanzate affiliate) has ~50 years of experience and established Italian healthcare relationships
Negatives
- Company disclosures note a history of recurring losses and substantial doubt about continued ability to operate as a going concern
- Commercial success depends on market adoption and any required regulatory clearances or third‑party arrangements
- Operational and business risks include geopolitical factors cited by the company (e.g., ongoing conflict in Israel)